Moderna - Stock Price History | MRNA
Historical daily share price chart and data for Moderna since 2023 adjusted for splits. The latest closing stock price for Moderna as of January 31, 2023 is 176.06.
- The all-time high Moderna stock closing price was 484.47 on August 09, 2021.
- The Moderna 52-week high stock price is 217.25, which is 23.4% above the current share price.
- The Moderna 52-week low stock price is 115.03, which is 34.7% below the current share price.
- The average Moderna stock price for the last 52 weeks is 156.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Moderna Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
156.6229 |
235.0500 |
235.0500 |
117.1300 |
179.6200 |
-29.28% |
| 2021 |
247.6753 |
111.7300 |
484.4700 |
109.1800 |
253.9800 |
143.11% |
| 2020 |
62.5042 |
19.2300 |
169.8600 |
17.7800 |
104.4700 |
434.10% |
| 2019 |
18.1192 |
15.3300 |
28.3400 |
12.2600 |
19.5600 |
28.09% |
| 2018 |
16.4338 |
18.6000 |
18.8000 |
13.5200 |
15.2700 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$67.639B |
$18.471B |
|
Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.
|
